Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 23,121 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 23,121 shares of the business’s stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $63.27, for a total transaction of $1,462,865.67. Following the transaction, the chief financial officer now owns 146,001 shares of the company’s stock, valued at $9,237,483.27. This represents a 13.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

James William Rogers also recently made the following trade(s):

• On Tuesday, March 18th, James William Rogers sold 23,030 shares of Tempus AI stock. The shares were sold at an average price of $45.97, for a total value of $1,058,689.10.

Tempus AI Stock Performance

NASDAQ:TEM opened at $59.25 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock has a market capitalization of $10.20 billion and a PE ratio of -7.60. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45. The company has a fifty day moving average of $51.22 and a two-hundred day moving average of $52.07.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The business’s revenue was up 75.4% on a year-over-year basis. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on TEM. Needham & Company LLC restated a “buy” rating and issued a $70.00 target price on shares of Tempus AI in a research note on Wednesday, May 7th. William Blair reaffirmed a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Bank of America increased their price target on shares of Tempus AI from $48.00 to $68.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, Wolfe Research cut shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $63.42.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds have recently made changes to their positions in TEM. Vanguard Group Inc. increased its position in shares of Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after purchasing an additional 5,900,668 shares in the last quarter. ARK Investment Management LLC boosted its stake in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. grew its holdings in shares of Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in shares of Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.